Shire plc and its subsidiaries (collectively referred to as either �Shire�, or
the �Company�) is a leading specialty biopharmaceutical company that focuses on
developing and marketing innovative specialty medicines that address significant
unmet patient needs.
The Company has grown through acquisition, completing a series of major
transactions that have brought therapeutic, geographic and pipeline growth and
diversification. The Company will continue to evaluate companies, products and
pipeline opportunities that offer a good strategic fit and have the potential to
deliver demonstrable value to all of the Company�s stakeholders: patients,
physicians, policy makers, payors, investors and employees.
Shire�s vision is to transform the lives of people around the world whose health
is impacted by rare and other specialized conditions, through providing